Literature DB >> 14676343

The incidence of deep vein thrombosis after hip and knee arthroplasties in Japanese patients: a prospective study.

A Sudo1, T Sano, K Horikawa, T Yamakawa, D Shi, A Uchida.   

Abstract

PURPOSE: To document the incidence of proximal deep vein thrombosis and pulmonary embolism in 58 consecutive Japanese patients undergoing total hip arthroplasty or total knee arthroplasty.
METHODS: Patients were routinely examined for proximal deep vein thrombosis by B-mode ultrasonography before and after surgery. Those patients who had ultrasonographic findings of deep vein thrombosis were also investigated for pulmonary embolism by ventilation-perfusion lung scan.
RESULTS: The incidence of deep vein thrombosis after total hip arthroplasty and total knee arthroplasty were 9.1% and 4.0% respectively, and the incidence of pulmonary embolism were 3.0% and 0%, respectively. There were no cases of fatal pulmonary embolism.
CONCLUSION: The incidence of deep vein thrombosis and pulmonary embolism in Japanese patients may have increased over the last few decades.

Entities:  

Mesh:

Year:  2003        PMID: 14676343     DOI: 10.1177/230949900301100212

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN: 1022-5536            Impact factor:   1.118


  10 in total

1.  Thromboembolic disease after knee arthroplasty is rare in Southern Iran.

Authors:  G Hossain Shahcheraghi; Mahzad Javid; Mohammad M Arasteh
Journal:  J Orthop       Date:  2014-01-31

2.  Incidences of Deep Vein Thrombosis and Pulmonary Embolism after Total Knee Arthroplasty Using a Mechanical Compression Device with and without Low-Molecular-Weight Heparin.

Authors:  Sin Hyung Park; Joong Hyeon Ahn; Yong Bok Park; Sun Geun Lee; Soo Jae Yim
Journal:  Knee Surg Relat Res       Date:  2016-08-25

3.  Deep vein thrombosis after total hip and knee arthroplasty in Indian patients.

Authors:  V Jain; B K Dhaon; A Jaiswal; V Nigam; J Singla
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401

4.  Evaluation of deep vein thrombosis with multidetector row CT after orthopedic arthroplasty: a prospective study for comparison with Doppler sonography.

Authors:  Sung Su Byun; Jeong Ho Kim; Youn Jeong Kim; Yong Sun Jeon; Yong Sun Chun; Chul Hi Park; Won Hong Kim
Journal:  Korean J Radiol       Date:  2008 Jan-Feb       Impact factor: 3.500

5.  Thromboprophylaxis for deep vein thrombosis and pulmonary embolism after total joint arthroplasty in a low incidence population.

Authors:  Kang-Il Kim; Dong-Geun Kang; Sumit S Khurana; Sang-Hak Lee; Young-Joo Cho; Dae-Kyung Bae
Journal:  Knee Surg Relat Res       Date:  2013-05-29

6.  The influence of tourniquet use and operative time on the incidence of deep vein thrombosis in total knee arthroplasty.

Authors:  Arnaldo José Hernandez; Adriano Marques de Almeida; Edmar Fávaro; Guilherme Turola Sguizzato
Journal:  Clinics (Sao Paulo)       Date:  2012-09       Impact factor: 2.365

7.  Is routine thromboprophylaxis justified among Indian patients sustaining major orthopedic trauma? A systematic review.

Authors:  Ramesh K Sen; Sujit K Tripathy; Amit K Singh
Journal:  Indian J Orthop       Date:  2011-05       Impact factor: 1.251

8.  Can Early Rehabilitation after Total Hip Arthroplasty Reduce Its Major Complications and Medical Expenses? Report from a Nationally Representative Cohort.

Authors:  Daniel Chiung-Jui Su; Kuo-Shu Yuan; Shih-Feng Weng; Rong-Bin Hong; Ming-Ping Wu; Hing-Man Wu; Willy Chou
Journal:  Biomed Res Int       Date:  2015-06-04       Impact factor: 3.411

9.  Postmarketing safety experience with edoxaban in Japan for thromboprophylaxis following major orthopedic surgery.

Authors:  Yasufumi Kuroda; Chie Hirayama; Hitoshi Hotoda; Yasuhiro Nishikawa; Akinori Nishiwaki
Journal:  Vasc Health Risk Manag       Date:  2013-10-07

10.  Venous Thromboembolism Following Hip and Knee Replacement Arthroplasty in Korea: A Nationwide Study Based on Claims Registry.

Authors:  Sahnghoon Lee; Jee-In Hwang; Yunjung Kim; Pil Whan Yoon; Jeonghoon Ahn; Jeong Joon Yoo
Journal:  J Korean Med Sci       Date:  2015-12-24       Impact factor: 2.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.